1. Short title This Act may be cited as the Affordable Insulin for the COVID–19 Emergency Act . 2. Eliminating cost-sharing with respect to coverage of insulin as a covered part D drug and associated medical supplies under the Medicare program during the COVID–19 emergency period (a) In general Section 1860D–2 of the Social Security Act ( 42 U.S.C. 1395w–102 ) is amended— (1) in subsection (b)— (A) in paragraph (1)(A), by striking The coverage and inserting Subject to paragraph (8), the coverage ; (B) in paragraph (2)— (i) in subparagraph (A), by inserting after Subject to subparagraphs (C) and (D) the following: and paragraph (8) ; (ii) in subparagraph (C)(i), by striking paragraph (4) and inserting paragraphs (4) and (8) ; and (iii) in subparagraph (D)(i), by striking paragraph (4) and inserting paragraphs (4) and (8) ; (C) in paragraph (4)(A)(i), by striking The coverage and inserting Subject to paragraph (8), the coverage ; and (D) by adding at the end the following new paragraph: (8) Elimination of cost-sharing for insulin and associated medical supplies during the COVID–19 emergency period The coverage does not impose any deductible, copayment, coinsurance, or other cost-sharing for insulin (as described in subparagraph (B) of subsection (e)(1)) or medical supplies associated with the injection of insulin (as described in such subparagraph) during the emergency period described in section 1135(g)(1)(B).